{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:01:35Z","timestamp":1782442895942,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dld.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T23:39:44Z","timestamp":1698881984000},"page":"923-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity"],"prefix":"10.1016","volume":"56","author":[{"given":"Nathan","family":"Calzadilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Zilberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hanscom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya T.","family":"Al Rashdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih","family":"Chacra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder K.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waddah A.","family":"Alrefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2023.10.006_bib0001","first-page":"147","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res"},{"key":"10.1016\/j.dld.2023.10.006_bib0002","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1053\/j.gastro.2016.02.043","article-title":"Alcoholic liver disease in Asia, Europe, and North America","volume":"150","author":"Liangpunsakul","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2023.10.006_bib0003","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2023.10.006_bib0004","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2468-2667(20)30062-1","article-title":"Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study","volume":"5","author":"Julien","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.dld.2023.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hep.32272","article-title":"Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: a modeling study","volume":"75","author":"Julien","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.10.006_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","article-title":"Pathogenesis of alcoholic liver disease","volume":"20","author":"Dunn","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2023.10.006_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2023.10.006_bib0008","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2021202232","article-title":"Noninvasive staging of liver fibrosis using 5-minute delayed dual-energy CT: comparison with US elastography and correlation with histologic findings","volume":"298","author":"Marri","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2023.10.006_bib0009","first-page":"759","article-title":"Cirrhosis: diagnosis and management","volume":"100","author":"Smith","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.dld.2023.10.006_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dld.2023.10.006_bib0011","unstructured":"The human serum metabolome - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/21359215\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0012","unstructured":"Serum metabolomics as a novel diagnostic approach for disease: a systematic review - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/22648167\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0013","unstructured":"Serum metabolomic profiling identifies key metabolic signatures associated with pathogenesis of alcoholic liver disease in humans - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/30976744\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0014","first-page":"107","article-title":"The clinical utility of FibroScan\u00ae as a noninvasive diagnostic test for liver disease","volume":"7","author":"Wilder","year":"2014","journal-title":"Med Devices"},{"key":"10.1016\/j.dld.2023.10.006_bib0015","unstructured":"A review of the alcohol use disorders identification test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/29723083\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0016","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"IMeta"},{"key":"10.1016\/j.dld.2023.10.006_bib0017","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.dld.2023.10.006_bib0018","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1002\/imt2.10","article-title":"Discriminating the origins of microbial metabolites for integrative analysis of the gut microbiome and metabolome","volume":"1","author":"Yu","year":"2022","journal-title":"IMeta"},{"key":"10.1016\/j.dld.2023.10.006_bib0019","unstructured":"Functional microbiomics reveals alterations of the gut microbiome and host co-metabolism in patients with alcoholic hepatitis - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/32766476\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0020","unstructured":"Metabolomic analysis uncovers energy supply disturbance as an underlying mechanism of the development of alcohol-associated liver cirrhosis - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/34141983\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0021","unstructured":"Integrative analysis of metabolome and microbiome in patients with progressive alcohol-associated liver disease - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/34822424\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0022","unstructured":"Neuroprotective effects of guanosine in ischemic stroke-small steps towards effective therapy - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/34199004\/[Accessed 6 March 2023]."},{"key":"10.1016\/j.dld.2023.10.006_bib0023","article-title":"AKR1D1 knockdown identifies 7[alpha]-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA) as a driver of metabolic dysfunction and hepatocellular cancer risk in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"81","author":"Nikolaou","year":"2022"},{"key":"10.1016\/j.dld.2023.10.006_bib0024","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13115","article-title":"Diabetes mellitus in patients with cirrhosis: clinical implications and management","volume":"36","author":"Elkrief","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2023.10.006_bib0025","doi-asserted-by":"crossref","first-page":"81321","DOI":"10.18632\/oncotarget.18466","article-title":"Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dld.2023.10.006_bib0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2013.09.006","article-title":"The impact of obesity and metabolic syndrome on alcoholic liver disease","volume":"18","author":"Chiang","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2023.10.006_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/cld.764","article-title":"Hypotension in cirrhosis","volume":"13","author":"Vora","year":"2019","journal-title":"Clin Liver Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823009945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823009945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:10:07Z","timestamp":1716617407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865823009945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1590865823009945"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.10.006","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}